Evidence map›Paper›PMID 35536023›Full record

ArticleMicrobiology spectrum2022

Metabolic Synergy between Human Symbionts

Jennie L Catlett, Sean Carr, Mikaela Cashman, Megan D Smith, Mary Walter, Zahmeeth Sakkaff, Christine Kelley, Massimiliano Pierobon, Myra B Cohen, Nicole R Buan

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Microbes as medicine.Annals of the New York Academy of Sciences · 2024
    Review
  16. Heliyon · 2024
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jennie L CatlettDepartment of Biochemistry, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
Sean CarrDepartment of Biochemistry, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
Mikaela CashmanBiosciences Division, Oak Ridge National Laboratorygrid.135519.a, Oak Ridge, Tennessee, USA.
Megan D SmithDepartment of Biochemistry, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
Mary WalterDepartment of Biochemistry, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
Zahmeeth SakkaffDepartment of Computer Science & Engineering, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
Christine KelleyDepartment of Mathematics, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
Massimiliano PierobonDepartment of Computer Science & Engineering, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
Myra B CohenDepartment of Computer Science & Engineering, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.
Nicole R BuanDepartment of Biochemistry, University of Nebraska-Lincoln, Lincoln, Nebraska, USA.ORCID 0000-0002-7560-973X
University of Nebraska–Lincoln · USOak Ridge National Laboratory · US

Funding

Targeted mass spectrometry approaches to understand CART processing and recepter interactionsP20GM113126 · NIGMS · UNIVERSITY OF NEBRASKA LINCOLN · PI RAZAVI RIZI, MOHAMMAD · 2016 to 2025
$20.8M
NIGMS NIH HHS P20 GM113126
6 · The paper itself

Abstract

Trophic interactions between microbes are postulated to determine whether a host microbiome is healthy or causes predisposition to disease. Two abundant taxa, the Gram-negative heterotrophic bacterium Bacteroides thetaiotaomicron and the methanogenic archaeon Methanobrevibacter smithii, are proposed to have a synergistic metabolic relationship. Both organisms play vital roles in human gut health; B. thetaiotaomicron assists the host by fermenting dietary polysaccharides, whereas M. smithii consumes end-stage fermentation products and is hypothesized to relieve feedback inhibition of upstream microbes such as B. thetaiotaomicron. To study their metabolic interactions, we defined and optimized a coculture system and used software testing techniques to analyze growth under a range of conditions representing the nutrient environment of the host. We verify that B. thetaiotaomicron fermentation products are sufficient for M. smithii growth and that accumulation of fermentation products alters secretion of metabolites by B. thetaiotaomicron to benefit M. smithii. Studies suggest that B. thetaiotaomicron metabolic efficiency is greater in the absence of fermentation products or in the presence of M. smithii. Under certain conditions, B. thetaiotaomicron and M. smithii form interspecies granules consistent with behavior observed for syntrophic partnerships between microbes in soil or sediment enrichments and anaerobic digesters. Furthermore, when vitamin B

Indexed as

Gastrointestinal MicrobiomeMethanobrevibacterBacteroidesFermentationHumansMicrobial InteractionsBacteroidescross-feedingmetabolismMethanobrevibactermicrobiomesynergysyntrophy

Identifiers

PMID35536023
PMCPMC9241691
OpenAlexW4229444014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.